AAAAAA
Results:
1-16
|
Results: 16
Authors:
SALTOGLU N
TASOVA Y
BURGUT R
DUNDAR IH
Citation: N. Saltoglu et al., SEXUAL AND NONSEXUAL INTRAFAMILIAL SPREAD OF HEPATITIS-C VIRUS - INTRAFAMILIAL TRANSMISSION OF HCV, European journal of epidemiology, 14(3), 1998, pp. 225-228
Authors:
ERKISI M
BILKAY BC
SEYREK E
HAZAR B
BURGUT R
Citation: M. Erkisi et al., REFRACTORY BREAST-CANCER - A COMPARISON OF 2 DIFFERENT CHEMOTHERAPY REGIMENS, Journal of chemotherapy, 9(6), 1997, pp. 442-445
Authors:
HASTURK S
KURT B
KOCABAS A
ORUC O
BURGUT R
Citation: S. Hasturk et al., IFOSFAMIDE, CISPLATIN AND ETOPOSIDE (ICE) COMBINED CHEMOTHERAPY WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN SMALL-CELL LUNG-CANCER, Journal of chemotherapy, 9(1), 1997, pp. 66-71
Authors:
ALTUNBASAK S
BAYTOK V
TASOUJI M
HERGUNER O
BURGUT R
KAYRIN L
Citation: S. Altunbasak et al., ASYMPTOMATIC HYPERAMMONEMIA IN CHILDREN TREATED WITH VALPROIC ACID, Journal of child neurology, 12(7), 1997, pp. 461-463
Authors:
ERKISI M
COLAKOGLU S
KOKSAL F
TUNCER I
BURGUT R
KARAKOSE H
DORAN F
ZORLUDEMIR S
Citation: M. Erkisi et al., RELATIONSHIP OF HELICOBACTER-PYLORI INFECTION TO SEVERAL MALIGNANT AND NONMALIGNANT GASTROINTESTINAL-DISEASES, Journal of experimental & clinical cancer research, 16(3), 1997, pp. 289-293
Authors:
ERKISI M
ERKURT E
OZBARLAS S
BURGUT R
DORAN F
SEYREK E
Citation: M. Erkisi et al., THE USE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR INCOMBINATION WITH SINGLE OR FRACTIONATED DOSES OF IFOSFAMIDE AND DOXORUBICIN IN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA, Journal of chemotherapy, 8(3), 1996, pp. 224-228
Authors:
KOCABAS A
KARA K
OZGUR G
SONMEZ H
BURGUT R
Citation: A. Kocabas et al., VALUE OF PREOPERATIVE SPIROMETRY TO PREDICT POSTOPERATIVE PULMONARY COMPLICATIONS, Respiratory medicine, 90(1), 1996, pp. 25-33
Authors:
ERKISI M
ERKURT E
OZBARLAS S
BURGUT R
DORAN F
SEYREK E
Citation: M. Erkisi et al., THE USE OF R-MET HU 6-CSF IN COMBINATION WITH HIGH AND STANDARD DOSESOF IFOSFAMIDE AND DOXORUBICIN IN THE PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA, European journal of cancer, 31A, 1995, pp. 855-855
Authors:
ERKISI M
DORAN F
BURGUT R
KOCABAS A
Citation: M. Erkisi et al., A RANDOMIZED TRIAL OF 2 CISPLATIN-CONTAINING CHEMOTHERAPY REGIMENS INPATIENTS WITH STAGE-III-B AND STAGE-IV NONSMALL CELL LUNG-CANCER, Lung cancer, 12(3), 1995, pp. 237-246
Authors:
PAYDAS S
YUREGIR GT
SAHIN B
SEYREK E
BURGUT R
Citation: S. Paydas et al., INTRACELLULAR GLUTATHIONE CONTENT IN LEUKEMIAS, Oncology, 52(2), 1995, pp. 112-115
Authors:
ERKISI M
DORAN F
BURGUT R
COLAKOGLU S
KARAER P
VARINLI S
Citation: M. Erkisi et al., ALPHA-FETOPROTEIN AND CARCINOEMBRYONIC ANTIGEN IN GASTRIC-CARCINOMA, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 253-256
Authors:
ERKISI M
DORAN F
BURGUT R
COLAKOGLU S
KARAER P
VARINLI S
Citation: M. Erkisi et al., ALPHA-FETOPROTEIN AND CARCINOEMBRYONIC ANTIGEN IN GASTRIC-CARCINOMA, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 253-256
Authors:
CETIN T
VARDAR MA
DEMIR C
BURGUT R
Citation: T. Cetin et al., ETIOLOGY OF SERUM CA-125 IN PATIENTS WITH ENDOMETRIOSIS TREATED WITH A GONADOTROPIN-RELEASING-HORMONE AGONIST (BUSERELIN), Gynecologic and obstetric investigation, 38(4), 1994, pp. 249-252
Authors:
PAYDAS S
SARPEL S
GILMANSACHS A
TUNCER I
PEHLIVAN S
TUNALI N
ZORLUDEMIR S
BURGUT R
KUCUK O
Citation: S. Paydas et al., DNA-PLOIDY, PROLIFERATIVE ACTIVITY, AND CONCANAVALIN-A REACTIVITY IN BREAST-CANCER, Journal of surgical oncology, 56(1), 1994, pp. 21-24
Authors:
ERKISI MK
BURGUT R
UNSAL M
ISPIR T
VARINLI S
KILICOGLU R
Citation: Mk. Erkisi et al., ADJUVANT USE OF ANTIPROLACTIN, ANTIESTROGEN, AND CYTOTOXIC CHEMOTHERAPY FOR BREAST-CANCER, Current therapeutic research, 55(1), 1994, pp. 67-75
Authors:
PAYDAS S
AKSU HSZ
PAYDAS S
BURGUT R
SAGLIKER Y
Citation: S. Paydas et al., THE PREVALENCE OF ANTI-HCV POSITIVITY IN PATIENTS UNDERGOING HEMODIALYSIS OR WITH MALIGNANT DISEASE, British journal of clinical practice, 48(1), 1994, pp. 25-26
Risultati:
1-16
|